Isoalvaxanthone (IAX) is a bioactive xanthone isolated from Cudrania cochinchinensis (Lour.). However, the function and mechanism of this compound in cancer migration and invasion have not been elucidated to date. In this study, we found that IAX could suppress various steps of tumor metastasis including proliferation, migration and invasion in a dose-dependent manner on colorectal cancer cells. Especially matrix metalloproteinase 2 (MMP-2), the pivotal factor in cancer invasion, was suppressed both on activation and expression after treated with IAX. To understand the underlying mechanism of IAX on the inhibitory effect of proliferation, migration and invasion, we demonstrated that IAX could significantly inhibit the activation of Rac1 but has undetectable effect on GTP-RhoA, GTP-Cdc42 and the phosphorylation of ERK1/2, p38 MAPK and JNK. Moreover, IAX showed little influence on the transcriptional activity of nuclear transcription factor jB (NF-jB) but strongly inhibited that of activator protein-1 (AP-1), which is the downstream transcriptional factor of Rac1. Together, our results indicate that IAX exerts anticancer effect in SW620 cells by targeting MMP-2 via regulating the activity of Rac1 and AP-1. These results are the first to reveal the function of IAX in tumor metastasis and its underlying molecular mechanism, thus suggest IAX to be a promising antimetastatic agent.Colorectal carcinoma is the third most common form of cancer and the second leading cause of morbidity and mortality in the world.1 Metastasis, a main cause of death in cancer patients, contributes to the high mortality of colorectal cancer, despite most early stage colorectal cancer is curable with surgical resection. In metastasis, malignant tumor cells moved from the primary tumor to a secondary distant organ through a complex multistage process involving the coordination of several signaling pathways that allow changes in cell morphology, migration and invasion.2,3 During the process of metastasis, degradation of the extracellular matrix (ECM) by proteases such as matrix metalloproteinases (MMPs) is important. MMP-2 (gelatinase A) and MMP-9 (gelatinase B) are the most vital proteases for the degradation of the main constituent of the basement membrane, type IV collagen and are, therefore, pivotal for cancer invasion and metastasis. 4 The Rho family proteins (RhoA, Rac1 and Cdc42) are small GTP-binding proteins with a distinct function in cell survival, cytoskeleton organization, adhesion and motility, thus become important targets of cancer chemotherapy. 5,6 It is now known that these biological activities are coordinated by the concerted action of different Rho/Rac subfamily members. For instance, RhoA function is required for the initial formation of the lamellipodia and the establishment of focal adhesions and stress fibers, Rac1 promotes membrane ruffles and lamellipodia and Cdc42 trigger filopodia in the leading edge of migrating cells.7 Small GTPases are also molecular switches that trigger signaling cascades in response to upstrea...